Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anticholinergic therapy for bronchiectasis.

T Lasserson1, K Holt, D Evans

  • 1Public Health Sciences, St George's Hospital Medical School, Cranmer Terrace, Tooting, London, UK, SW17 0RE. tlassers@sghms.ac.uk

The Cochrane Database of Systematic Reviews
|November 1, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Observation of sequential Υ suppression in PbPb collisions.

Physical review letters·2013
Same author

Study of the Dijet mass spectrum in pp → W+jets events at sqrt[s] = 7 TeV.

Physical review letters·2013
Same author

Pion, kaon, and proton production in central Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV.

Physical review letters·2013
Same author

Implementing a community-based obesity prevention programme: experiences of stakeholders in the north east of England.

Health promotion international·2013
Same author

Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV.

Physical review letters·2012
Same author

Removal of TSE agent from plasma products manufactured in the United Kingdom.

Vox sanguinis·2012
Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026
Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
See all related articles

Anticholinergic therapy is not recommended for bronchiectasis due to insufficient evidence. Current research lacks randomized controlled trials to support its use in acute or stable conditions.

Area of Science:

  • Pulmonology
  • Pharmacology

Background:

  • Anticholinergic agents inhibit vagus nerve-mediated bronchoconstriction and reduce bronchial secretions.
  • These agents are effective in obstructive airways disease and may benefit bronchiectasis patients.

Purpose of the Study:

  • To evaluate the efficacy of anticholinergic therapy in managing acute exacerbations and stable states of bronchiectasis.

Main Methods:

  • A systematic search of the Cochrane Airways Group clinical trials register was conducted.
  • Search terms included 'bronchiectasis' AND 'anticholinergic' OR 'ipratropium bromide' OR 'tiotropium' OR 'atropine'.
  • Only randomized controlled trials were included, with independent review by two researchers.

Main Results:

  • Twelve studies were initially identified, with six selected for further review.

Related Experiment Videos

  • One study required translation from Italian.
  • Critically, none of the reviewed studies met the inclusion criteria for the analysis.

    • Conclusions:

    • The available literature is insufficient to support formal recommendations on anticholinergic therapy for bronchiectasis.
    • Further high-quality randomized controlled trials are needed to establish the role of these agents in bronchiectasis management.